Anavex Life Sciences Corp.
Simbol: AVXL
NASDAQ
3.85
USDPrețul de piață astăzi
-7.3224
Raportul P/E
-2.2699
Raportul PEG
311.23M
MRK Cap
- 0.00%
Randament DIV
Anavex Life Sciences Corp. (AVXL) Situații financiare
Bilanț
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 603.07 | 151 | 149.2 | 152.1 | ||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.net-receivables | 13.16 | 2.7 | 3.2 | 9.1 | ||||||||||||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.other-current-assets | 3.22 | 0.7 | 0.4 | 0.4 | ||||||||||||||||||||
balance-sheet.row.total-current-assets | 619.45 | 154.4 | 152.7 | 161.6 | ||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 3.36 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 3.36 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.other-assets | 8713.08 | 3.4 | 3546.7 | 0 | ||||||||||||||||||||
balance-sheet.row.total-assets | 619.45 | 154.4 | 152.7 | 161.6 | ||||||||||||||||||||
balance-sheet.row.account-payables | 19.05 | 4.3 | 3.8 | 4.7 | ||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0 | 0 | ||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||||
balance-sheet.row.other-current-liab | 27.39 | 7.3 | 5.9 | 5.6 | ||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 12823.08 | 7.3 | 4.3 | 5.6 | ||||||||||||||||||||
balance-sheet.row.other-liabilities | -12823.08 | -7.3 | -4.3 | -5.6 | ||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-liab | 50.11 | 12.5 | 10.2 | 10.8 | ||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.common-stock | 0.33 | 0.1 | 0.1 | 0.1 | ||||||||||||||||||||
balance-sheet.row.retained-earnings | -1149.33 | -293.1 | -245.6 | -197.6 | ||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1718.35 | 434.8 | 388 | 348.3 | ||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 569.35 | 141.9 | 142.5 | 150.8 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 619.45 | 154.4 | 152.7 | 161.6 | ||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-equity | 569.35 | 141.9 | 142.5 | 150.8 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 619.45 | - | - | - | ||||||||||||||||||||
Total Investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.net-debt | -603.07 | -151 | -149.2 | -152.1 |
Situația fluxurilor de numerar
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -43.16 | -47.5 | -48 | -37.9 | ||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.stock-based-compensation | 13.31 | 16.4 | 18.4 | 8.2 | ||||||||||||||||||||
cash-flows.row.change-in-working-capital | -0.31 | 2.5 | 5.4 | -0.7 | ||||||||||||||||||||
cash-flows.row.account-receivables | 0.55 | 0.5 | 5.9 | -4.3 | ||||||||||||||||||||
cash-flows.row.inventory | -1.53 | -0.5 | -5.9 | 4.3 | ||||||||||||||||||||
cash-flows.row.account-payables | -1 | 0.5 | -0.9 | 0.8 | ||||||||||||||||||||
cash-flows.row.other-working-capital | 1.67 | 2 | 6.3 | -1.5 | ||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0.84 | 0.8 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -29.31 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.common-stock-issued | 27.93 | 27.9 | 21 | 153.2 | ||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.other-financing-activites | 1.52 | 1.8 | 0.3 | 0 | ||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 29.45 | 29.7 | 21.3 | 153.2 | ||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0.14 | 1.9 | -2.9 | 122.9 | ||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 603.07 | 151 | 149.2 | 152.1 | ||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 602.93 | 149.2 | 152.1 | 29.2 | ||||||||||||||||||||
cash-flows.row.operating-cash-flow | -29.31 | -27.8 | -24.2 | -30.4 | ||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.free-cash-flow | -29.31 | -27.8 | -24.2 | -30.4 |
Rândul din contul de profit și pierdere
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.research-development | 40.33 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 11.33 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-expenses | 2.58 | 2.7 | 3.3 | -0.1 | ||||||||||||||||||||
income-statement-row.row.operating-expenses | 51.67 | 55.8 | 51 | 41.9 | ||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 51.67 | 55.8 | 51 | 41.9 | ||||||||||||||||||||
income-statement-row.row.interest-income | 7.26 | 6.5 | 0.9 | 0 | ||||||||||||||||||||
income-statement-row.row.interest-expense | -1.13 | 1 | 0.9 | 0 | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 2.83 | 2.7 | 6.8 | 4.3 | ||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 2.58 | 2.7 | 3.3 | -0.1 | ||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 2.83 | 2.7 | 6.8 | 4.3 | ||||||||||||||||||||
income-statement-row.row.interest-expense | -1.13 | 1 | 0.9 | 0 | ||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 2.23 | 0 | 4.3 | 0.2 | ||||||||||||||||||||
income-statement-row.row.ebitda-caps | -46.68 | - | - | - | ||||||||||||||||||||
income-statement-row.row.operating-income | -48.91 | -47.5 | -54.4 | -41.9 | ||||||||||||||||||||
income-statement-row.row.income-before-tax | -43.04 | -47.5 | -47.6 | -37.6 | ||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0.11 | 0 | 0.4 | 0.3 | ||||||||||||||||||||
income-statement-row.row.net-income | -43.16 | -47.5 | -48 | -37.9 |
Întrebări frecvente
Ce este Anavex Life Sciences Corp. (AVXL) totalul activelor?
Anavex Life Sciences Corp. (AVXL) activele totale sunt 154386000.000.
Care este venitul anual al întreprinderii?
Venitul anual este N/A.
Care este marja de profit a întreprinderii?
Marja de profit a firmei este 0.000.
Care este fluxul de numerar liber al întreprinderii?
Fluxul de numerar liber este -0.357.
Care este marja de profit net a întreprinderii?
Marja profitului net este 0.000.
Care este venitul total al întreprinderii?
Venitul total este 0.000.
Care este Anavex Life Sciences Corp. (AVXL) profitul net (venitul net)?
Profitul net (venitul net) este -47491000.000.
Care este datoria totală a firmei?
Datoria totală este 0.000.
Care este numărul cheltuielilor de exploatare?
Cheltuielile de exploatare sunt 55756000.000.
Care este cifra de numerar a firmei?
Numerarul întreprinderii este 143765000.000.